LIF and breast carcinoma: Given that LIF is frequently overexpressed in breast cancer, results from this study reveal an important mechanism underlying metabolic reprogramming of breast cancer, and identify LIF and its relevant downstream signaling as potential therapeutic targets for breast cancer, especially those with LIF overexpression.